Jim Cramer Says Stryker and Its Orthopedic Peers Are Facing a Real Tough Run

Stryker Corporation (NYSE:SYK) was among the stocks on Jim Cramer’s radar on Mad Money, as he advised investors to care about where a stock is going, not where it has been. Toward the end of the lightning round, a caller asked if the stock is a buy, sell, or hold. In response, Cramer said:

See, I kept thinking that there would be a consolidator and Stryker would do the consolidating and J&J’s spinning off its orthopedics, too. And it has not come true… And I’m kind of bummed because I thought that that group, which was Zimmer, Biomet, and Stryker, I thought they would work out something, and they haven’t, and it’s been a real tough run.

A stock market graph. Photo by energepic.com

Stryker Corporation (NYSE:SYK) supplies medical technologies, including surgical equipment, joint replacement implants, robotic applications, and AI-assisted virtual care platforms. During the episode aired on May 23, 2025, a caller asked about the stock, and Cramer responded:

I like Stryker, but you know, I don’t like it enough. I don’t like it as much as if it was Intuitive Surgical. That’s the one that I thought we should buy. ISRG.

It is worth noting that since the above comment was aired, Stryker Corporation’s (NYSE:SYK) stock has declined by around 17%.

While we acknowledge the risk and potential of SYK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than SYK and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.

1470453 - 11759070 - 1